Academia.eduAcademia.edu

Figure from:Avian influenza revisited: concerns and constraints

See full PDFdownloadDownload figure
Fig. 3. Symptomatology in Low pathogenic Avian Influenza (LPAI) and High Pathogenic Avian Influenza (HPAI)

Figure 3 Symptomatology in Low pathogenic Avian Influenza (LPAI) and High Pathogenic Avian Influenza (HPAI)

Related Figures (4)

Fig. 1 Schematic structure of influenza virion: Hemagglutinin (HA) and neuraminidase (NA) are surface proteins present at an approxi- mate 3:1 ratio along with M2 ion channels. M1 is the matrix protein The ability for the virus to cross species barrier is multi- factorial (Fig. 2). The presence of intermediate host (viz. pigs) where it acts as a genetic mixing vessel among humans and birds, along with host susceptibility, exposure level to infected avian species, viral mutations, environmental con- ditions conducive for virus transmission are essential for transmission [8, 42]. Pigs and birds have been implicated
Fig. 1 Schematic structure of influenza virion: Hemagglutinin (HA) and neuraminidase (NA) are surface proteins present at an approxi- mate 3:1 ratio along with M2 ion channels. M1 is the matrix protein The ability for the virus to cross species barrier is multi- factorial (Fig. 2). The presence of intermediate host (viz. pigs) where it acts as a genetic mixing vessel among humans and birds, along with host susceptibility, exposure level to infected avian species, viral mutations, environmental con- ditions conducive for virus transmission are essential for transmission [8, 42]. Pigs and birds have been implicated
Fig. 2 Host Range Restriction and transmission to humans
Fig. 2 Host Range Restriction and transmission to humans
Also, Tablet Temiflu (75 mg twice daily) should be given as prophylaxis for 10 days for symptomatic people and their contacts. Samples should be tested for AVI by RT-PCR fol- lowing all recommended BSL-3 facility [5].
Also, Tablet Temiflu (75 mg twice daily) should be given as prophylaxis for 10 days for symptomatic people and their contacts. Samples should be tested for AVI by RT-PCR fol- lowing all recommended BSL-3 facility [5].
Fig. 5 Schematic representation for disposal of poultry infected with Avian influenza
Fig. 5 Schematic representation for disposal of poultry infected with Avian influenza